Healthcare Professionals Investor Login Turkish
About Trustlife Labs Drug R&D Center News Contact
Trustlife

Patents

Parbendazole For Use In The Treatment Of Dementia - PCT

AlzheimerPatent

12.09.2024

Parbendazole For Use In The Treatment Of Dementia - PCT from TRUSTLIFE

Abstract:

There is provided a product for use in a method of prevention or treatment of dementia, wherein the product is or bortezomib or parbendazole.

You may also be interested in

  • Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife
    Visits

    Visit of Minister of Health Prof. Dr. Kemal Memişoğlu to Trustlife

  • Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH
    Scientific Documents

    Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH

  • Novel pyrimidine derivatives as potent BUB1B inhibitors for clear cell renal cell carcinoma: From synthesis and characterization to docking insights and therapeutic validation
    Scientific Documents

    Novel pyrimidine derivatives as potent BUB1B inhibitors for clear cell renal cell carcinoma: From synthesis and characterization to docking insights and therapeutic validation

Trustlife
About Trustlife Labs Drug R&D Center Contact